CLINICAL_TRIALS
trial_result
· 2025-12-09
Clinical Trial Update: Evaluation the Safety of hemay005 Tablets [Phase 1]
Summary
Phase 1 safety evaluation of hemay005 tablets in chronic obstructive pulmonary disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Anhui Hemay Pharmaceutical Co., Ltd | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED